Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?

Steffen IG, Weissmann T, Rothe JH, Geisel D, Chopra SS, Kahn J, Hamm B, Denecke T

Open source

DOI
10.3390/jcm10010098
Published
2020 Dec 30
Container
Journal of clinical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm10010098,
  title = {Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?},
  author = {Steffen IG and Weissmann T and Rothe JH and Geisel D and Chopra SS and Kahn J and Hamm B and Denecke T},
  year = {2020},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm10010098},
  url = {https://doi.org/10.3390/jcm10010098}
}

RIS

TY  - JOUR
TI  - Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?
AU  - Steffen IG
AU  - Weissmann T
AU  - Rothe JH
AU  - Geisel D
AU  - Chopra SS
AU  - Kahn J
AU  - Hamm B
AU  - Denecke T
PY  - 2020
JO  - Journal of clinical medicine
DO  - 10.3390/jcm10010098
UR  - https://doi.org/10.3390/jcm10010098
ER  - 

APA

IG, S., T, W., JH, R., D, G., SS, C., J, K., B, H., & T, D. (2020). Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?. Journal of clinical medicine. https://doi.org/10.3390/jcm10010098

Source records